Erste Group Bank Brokers Reduce Earnings Estimates for Roche

Roche Holding AG (OTCMKTS:RHHBY) – Equities researchers at Erste Group Bank lowered their FY2027 earnings per share (EPS) estimates for Roche in a research report issued on Thursday, June 25th. Erste Group Bank analyst H. Engel now expects that the company will post earnings per share of $3.34 for the year, down from their prior forecast of $3.42. The consensus estimate for Roche’s current full-year earnings is $3.29 per share.

RHHBY has been the subject of several other research reports. Argus raised Roche from a “hold” rating to a “buy” rating in a report on Monday, April 6th. Morgan Stanley upgraded shares of Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 target price on the stock in a report on Friday, April 24th. Five analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $51.50.

Roche Stock Performance

OTCMKTS:RHHBY opened at $51.35 on Wednesday. Roche has a twelve month low of $37.51 and a twelve month high of $60.85. The company has a quick ratio of 1.12, a current ratio of 1.38 and a debt-to-equity ratio of 0.72. The stock’s 50 day moving average price is $51.21 and its two-hundred day moving average price is $52.65.

Hedge Funds Weigh In On Roche

Institutional investors have recently bought and sold shares of the business. Oakworth Capital Inc. lifted its position in shares of Roche by 20.8% in the fourth quarter. Oakworth Capital Inc. now owns 1,658 shares of the company’s stock valued at $86,000 after buying an additional 285 shares during the last quarter. Enterprise Financial Services Corp increased its holdings in shares of Roche by 6.6% during the 1st quarter. Enterprise Financial Services Corp now owns 5,576 shares of the company’s stock worth $277,000 after acquiring an additional 345 shares during the last quarter. Archer Investment Corp increased its holdings in shares of Roche by 7.7% during the 1st quarter. Archer Investment Corp now owns 5,598 shares of the company’s stock worth $278,000 after acquiring an additional 398 shares during the last quarter. Diversified Trust Co raised its stake in Roche by 0.8% in the 1st quarter. Diversified Trust Co now owns 59,375 shares of the company’s stock valued at $2,907,000 after acquiring an additional 448 shares during the period. Finally, Fulton Bank N.A. raised its stake in Roche by 4.6% in the 4th quarter. Fulton Bank N.A. now owns 11,659 shares of the company’s stock valued at $604,000 after acquiring an additional 508 shares during the period.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann?La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.